The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.
about
Polyomaviruses and disease: is there more to know than viremia and viruria?Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survivalBK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Nationwide survey of BK polyomavirus associated hemorrhagic cystitis in adult allogeneic stem cell transplantation among haematologists and urologists.Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?Incidence, risk factors and the effect of polyomavirus infection in hematopoietic stem cell transplant recipients.Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation.Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population.Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo.
P2860
Q28081350-5C8AFC00-0D2D-48B8-BDE9-B3CC38189093Q33424344-13C7AE07-382B-4BB6-973D-AABFE46E6A03Q37375153-741DD0C6-A47E-4C6F-A555-A39C32BBC5AEQ38801394-9F0015B8-D33C-4A47-B630-734713DA7358Q38979770-8DE9BB0B-0C2B-4452-A72D-64E1E4FB1B35Q40168823-F5CC91F2-4078-4215-AD43-1CBAD9330DFEQ40239932-B760AC65-9132-47FD-832E-7AA3C89246B8Q40246511-8CAAB5C2-8672-44AD-8072-11B48C038293Q40332245-E66727C5-EBE5-4A7B-BB30-B7D7B9649C1BQ40824434-B49B6A0E-DCD6-4A3C-B73D-50C09339FCB5Q40892420-9D311163-34CB-421F-91C1-BD1CC880AFC0Q40895043-8DA9CDE8-03E8-44FE-AA8A-ADA28D3DB08CQ41008103-6E8C53B0-2298-4862-B36C-3BE0AF988D9BQ47159198-0CD265F7-8B9A-416F-9707-9DBFD4B81B4B
P2860
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@en
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@nl
type
label
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@en
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@nl
prefLabel
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@en
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@nl
P2093
P2860
P356
P1476
The risk of polyomavirus BK-as ...... viremia and severe acute GVHD.
@en
P2093
F V Michelis
H A Messner
J H Lipton
J Kuruvilla
P2860
P2888
P304
P356
10.1038/BMT.2014.181
P407
P577
2014-08-11T00:00:00Z
P5875
P6179
1033068013